TP53 and colorectal carcinoma: CRISPR-mediated inactivation of Dicer markedly elevated the expression of p53 targets, such as p21 and PUMA, without affecting the steady-state levels of endogenous p53 in HCT116 colorectal carcinoma cells (lane 3, Fig. 2A; fig.